Want to join the conversation?
$PFE said it will acquire AstraZeneca's development and commercialization rights to its late-stage small molecule anti-infectives business, mainly outside the US. Deal includes rights for Zavicefta, marketed agents Merrem/Meronem and Zinforo, and clinical development assets aztreonam-avibactam and CXL. The deal is expected to close in 4Q16.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.